Chapter title |
The Nuclear Receptor Superfamily at Thirty
|
---|---|
Chapter number | 1 |
Book title |
The Nuclear Receptor Superfamily
|
Published in |
Methods in molecular biology, January 2016
|
DOI | 10.1007/978-1-4939-3724-0_1 |
Pubmed ID | |
Book ISBNs |
978-1-4939-3722-6, 978-1-4939-3724-0
|
Authors |
Iain J. McEwan, McEwan, Iain J. |
Abstract |
The human genome codes for 48 members of the nuclear receptor superfamily, half of which have known ligands. Natural ligands for nuclear receptors are generally lipophilic in nature and include steroid hormones, bile acids, fatty acids, thyroid hormones, certain vitamins, and prostaglandins. Nuclear receptors regulate gene expression programs controlling development, differentiation, metabolic homeostasis and reproduction, in both a temporal and a tissue-selective manner. Since the original cloning of the cDNAs for the estrogen and glucocorticoid receptors, large strides have been made in our understanding of the structure and function of this family of transcription factors and their role in pathophysiology. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 43 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 28% |
Researcher | 11 | 26% |
Student > Master | 4 | 9% |
Student > Doctoral Student | 3 | 7% |
Student > Bachelor | 2 | 5% |
Other | 3 | 7% |
Unknown | 8 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 16 | 37% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
Agricultural and Biological Sciences | 4 | 9% |
Chemistry | 3 | 7% |
Medicine and Dentistry | 2 | 5% |
Other | 4 | 9% |
Unknown | 10 | 23% |